Aclaris Therapeutics
NASDAQ:ACRS
Develops innovative therapies for unmet needs in dermatology and immunodermatology.
Develops innovative therapies for unmet needs in dermatology and immunodermatology.
Sector
Life SciencesCategory
TherapeuticsLocation
Malvern, PAInitial Investment
2012Aclaris Therapeutics, Inc. (NASDAQ:ACRS) is a dermatologist-led biopharmaceutical company committed to identifying, developing and commercializing innovative therapies to address significant unmet needs in aesthetic and medical dermatology and immunodermatology.